NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Octagon Research Solutions, Inc. Chairman and CEO Named to PharmaVOICE 100 2010 - PharmaVOICE’s multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven
Octagon Research Solutions, Inc. Chairman and CEO Named to PharmaVOICE 100 2010

 

NewswireTODAY - /newswire/ - Wayne, PA, United States, 2010/08/16 - PharmaVOICE’s multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Octagon congratulates James Walker, the company’s Chairman and CEO, on earning a place on the PharmaVOICE 100, a list recognizing the most inspiring people in the Life Sciences industry.
• In the special Jul y/August issue, PharmaVOICE (pharmavoice.com) reveals its annual list of the 100 most inspiring and motivating people in the life-sciences industry as identified by the publication’s readers.
• Jim Walker founded Octagon Research Solutions, Inc. in 1999 with a laser focus on creating an entrepreneurial organization that delivers innovative solutions and unprecedented customer service. Today, Jim continues to lead the company in delivering and expanding on this vision while guiding the industry toward more efficient and effective R&D processes.
• Established six years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry.
• The distinguished honorees are nominated by thousands of PharmaVOICE readers. The PharmaVOICE 100 are selected based on well-crafted and comprehensive essays describing how individuals inspired or motivated our readers or affected positive changes within their companies, communities, and the industry at large, as well as other factors, such as community and philanthropic activities.
• The PharmaVOICE 100 represents a broad cross section of industry sectors, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, regulatory, technology, and many others. Furthermore, the leaders chosen as this year’s most inspiring representatives within the industry have accomplishments that are diverse; this group of thought leaders contribute to the growth and well-being of not only their companies, but to their communities as well as varied industry associations.

Supporting Quotes

• As PharmaVOICE Editor Taren Grom writes in her Letter from the Editor, “It is our extreme pleasure to once again be able to pay tribute to the men and women who are driving change, providing guidance, and fostering relationships to position the industry in the best way possible to serve the ultimate stakeholders: patients. This special issue, now in its sixth year, has become a must-read and one of the most-anticipated publications of the year.”

• “I am honored to be named to the PharmaVOICE 100 for 2010,” commented Walker. “I am inspired daily by an extremely dynamic and talented team of accomplished regulatory, clinical, process and technology professionals dedicated to improving R&D processes from clinical data collection to regulatory submission. Recognition in the PharmaVOICE 100 for 2010 is a great motivator for me and our entire organization.’

Supporting Resources
• To download a digital version of the July/August issue, please visit pharmavoice.com/.

About Octagon Research Solutions, Inc.
Octagon (octagonresearch.com) is a pioneer and leading provider of breakthrough software and services to the life sciences industry. Octagon’s eCTD and CDISC solutions provide the people, process, and technology required to optimize drug development from data collection to submission. Our regulatory, clinical, process and software offerings provide a unique combination of deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in London, UK. Octagon’s EDC Operations are located in Mountain View, CA.

About PharmaVOICE
PharmaVOICE (pharmavoice.com) is expressly written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 17,500 readers every month in print and 70,000 with its digital edition.

PharmaVOICE’s unique horizontal editorial approach cuts across industry silos, providing a holistic overview of the life-sciences industry, addressing a range of topics from molecule through market. By engaging compelling personalities from diverse industry sectors, PharmaVOICE provides multiple perspectives on business challenges, trends, and topics. Editorial content sparks dialogue, initiates debate, and opens the lines of communication to facilitate and improve business-to-business relationships.

PharmaVOICE’s multiple-perspective and in-depth original forums, feature articles, topics, and departments are audience-driven. PharmaVOICE provides executives with useful peer-to-peer insights on a broad range of business practices and topics, including, but not limited to the following life-science sectors:

Advertising – Government
Analysts – Healthcare Professionals
Associations – Information Technology
Big Pharma – Legal
Biotech – Marketing
Clinical Services – Medical Devices
Communications – Medical Education
Consultants – Public Relations
Contract Research – Regulatory
Contract Sales – Research & Development
Device/Diagnostic – Service Support
Drug Delivery – Specialty Pharma
Drug Discovery – Traditional and Nontraditional Media
Emerging Pharma – Venture Capital

For more information, contact: Taren Grom, Editor, tgrom[.]pharmavoice.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Octagon Research Solutions, Inc. Chairman and CEO Named to PharmaVOICE 100 2010

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Kathleen Bouldin - OctagonResearch.com 
610-535-8500 x5556 Kbouldin[.]octagonresearch.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)